| Literature DB >> 31979231 |
Mudassir Shah1, Chunxiao Sun1, Zichao Sun1, Guojian Zhang1,2, Qian Che1, Qianqun Gu1, Tianjiao Zhu1, Dehai Li1,2,3.
Abstract
Three new polyketides, ketidocillinones A-C (1-3), were discovered from the extract of an Antarctica sponge-derived fungus Penicillium sp. HDN151272. All the structures were deduced by spectroscopic data, including NMR and HRESIMS. The absolute configuration of compound 3 was established by using ECD calculation. Compounds 1-3 can be slowly oxidized to quinone form when exposed to air. Ketidocillinones B and C (2 and 3) exhibited potent antibacterial activity against Pseudomonas aeurigenosa, Mycobacterium phlei, and MRCNS (methicillin-resistant coagulase-negative staphylococci) with MIC values ranging from 1.56 to 25.00 µg/mL.Entities:
Keywords: Antarctica sponge-derived fungus; Penicillium sp.; antibacterial activity; polyketides
Year: 2020 PMID: 31979231 PMCID: PMC7073682 DOI: 10.3390/md18020071
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–3.
1H (500 MHz, J in Hz) NMR and 13C (125 MHz) NMR data for compounds 1−3 in DMSO-d6.
| No. | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
| 1H | 13C (Type) | 1H | 13C (Type) | 1H | 13C (Type) | |
| 1 | 147.5, C | 147.5, C | 147.5, C | |||
| 2 | 126.0, C | 125.9, C | 125.4, C | |||
| 3 | 6.44, s | 116.2, CH | 6.44, s | 117.4, CH | 6.41, s | 116.2, CH |
| 4 | 147.9, C | 147.9, C | 147.9, C | |||
| 5 | 121.7, C | 121.8, C | 121.9, C | |||
| 6 | 6.44, s | 117.5, CH | 6.43, s | 116.3, CH | 6.44, s | 117.5, CH |
| 7 | 2.48, m | 28.7, CH2 | 2.46, m | 28.6, CH2 | 2.36, ov. | 27.3, CH2 |
| 8 | 2.12, m | 39.9, CH2 | 2.13, t (8.5) | 39.8, CH2 | 1.53, m | 33.9, CH2 |
| 1.75, m | ||||||
| 9 | 138.2, C | 138.9, C | 2.36, ov. | 38.6, CH | ||
| 10 | 5.26, t (7.2) | 116.8, CH | 5.24, m | 116.1, CH | 176.7, C | |
| 11 | 2.93, d (7.1) | 33.7, CH2 | 3.03, d (7.1) | 33.3, CH2 | 3.58, s | 51.7, CH3 |
| 12 | 173.5, C | 172.4, C | 1.97, s | 16.2, CH3 | ||
| 13 | 3.57, s | 51.8, CH3 | 1.08, s | 17.2, CH3 | ||
| 14 | 1.60, s | 16.7, CH3 | 1.61, s | 16.7, CH3 | ||
| 15 | 1.97, s ov. | 16.2,CH3 | 1.97, s | 16.2, CH3 | ||
| 1-OH | 8.34, s | 8.35, s | 8.35, s | |||
| 4-OH | 8.30, s | 8.31, s | 8.33, s | |||
Figure 2Key COSY and HMBC correlations of 1.
Figure 3Key COSY and HMBC correlations of compounds 2–3.
Figure 4Calculated and experimental ECD spectra of 3 in DMSO.
Figure 5Oxidative transformation of 1–3.
1H (500 MHz, J in Hz) NMR data for compounds 1–3 in CDCl3.
| No. | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
| a | b | a | b | a | b | |
| 3 | 6.53, ov. | 6.53, ov. | 6.55, ov. | 6.55, ov. | 6.55, s | 6.52, s |
| 6 | 6.53, ov. | 6.53, ov. | 6.55, ov. | 6.55, ov. | 6.59, s | 6.62, s |
| 7 | 2.51, t (7.5) | 2.62, m | 2.53, t (7.4) | 2.65, t (7.5) | 2.42, m | 2.52, ov. |
| 8 | 2.20, t (7.5) | 2.26, t (7.8) | 2.23, t (7.4) | 2.28, t (7.5) | 1.88, ov. | 1.89, ov. |
| 1.62, m | 1.71, m | |||||
| 9 | 2.51, ov. | 2.51, ov. | ||||
| 10 | 5.32, ov. | 5.28, ov. | 5.32, t (6.4) | 5.28,t (6.9) | ||
| 11 | 3.02, ov. | 3.02, ov. | 3.04, ov. | 3.04, ov. | 3.68, s | 3.72, s |
| 12 | 2.04, s | 2.17, s | ||||
| 13 | 3.67, s | 3.68, s | 1.19, ov. | 1.20, ov. | ||
| 14 | 2.00, s | 2.12, s | 2.03, s | 2.16, s | ||
| 15 | 1.64, s | 1.65, s | 1.66, s | 1.68, s | ||
ov. Overlapped signals.
13C (125 MHz) NMR data for compounds 1–3 in CDCl3.
| No. | 1 (Type) | 2 (Type) | 3 (Type) | |||
|---|---|---|---|---|---|---|
| a | b | a | b | a | b | |
| 1 | 147.6, C | 185.9, C | 146.9, C | 187.6, C | 147.7, C | 187.5, C |
| 2 | 127.0, C | 148.8, C | 126.7, C | 148.7, C | 125.6, C | 148.6, C |
| 3 | 117.6, CH | 132.9, CH | 116.7, CH | 132.8, CH | 116.3, CH | 132.7, CH |
| 4 | 147.7, C | 187.7, C | 147.6, C | 188.1, C | 147.3, C | 188.1, C |
| 5 | 122.1, C | 145.6, C | 122.2, C | 145.6, C | 122.7, C | 145.7, C |
| 6 | 118.0, CH | 133.6, CH | 118.0, CH | 133.5, CH | 118.3, CH | 133.6, CH |
| 7 | 29.8, CH2 | 27.2, CH2 | 27.9, CH2 | 27.1, CH2 | 27.6, CH2 | 26.5, CH2 |
| 8 | 39.8, CH2 | 37.7, CH2 | 39.7, CH2 | 37.6, CH2 | 34.0, CH2 | 31.5, CH2 |
| 9 | 138.2, C | 137.3, C | 139.2, C | 137.3, C | 38.7, CH | 39.0, CH |
| 10 | 116.9, CH | 118.0, CH | 116.3, CH | 117.2, CH | 177.9, C | 176.5, C |
| 11 | 33.6, CH2 | 33.4, CH2 | 33.5, CH2 | 33.5, CH2 | 52.0, CH3 | 51.7, CH3 |
| 12 | 173.7, C | 171.9, C | 173.2, C | 172.5, C | 15.5, CH3 | 15.5, CH3 |
| 13 | 51.9, CH3 | 51.8, CH3 | 17.3, CH3 | 17.1, CH3 | ||
| 14 | 15.5, CH3 | 15.7, CH3 | 15.4, CH3 | 15.5, CH3 | ||
| 15 | 16.7, CH3 | 16.3, CH3 | 16.5, CH3 | 16.2, CH3 | ||
Antibacterial activity for compounds 1–3 (mixtures of the phenol and quinone products) (MIC, µg/mL).
| Compd. |
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
| >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 |
|
| >50 | >50 | >50 | >50 | 6.25 | 12.50 | 1.56 | 3.13 | >50 |
|
| 12.50 | >50 | >50 | 12.50 | 6.25 | 25.00 | 6.25 | 6.25 | >50 |
| Ciprofloxacin | 0.52 | 2.07 | 0.52 | 0.98 | 0.98 | 0.98 | 0.98 | 3.91 | 3.91 |